Ultrashort Nasdaq Biotech Proshares (BIS) 26.28 $B
Post# of 273323
Posted On: 08/01/2015 2:49:10 AM
Ultrashort Nasdaq Biotech Proshares (BIS) 26.28 $BIS
What The ECB Will Do
Chuck Butler - Daily Reckoning - Tue Jun 30, 9:35AM CDT
This post What The ECB Will Do appeared first on Daily Reckoning . Chuck Butler explains the breakdown of the Greek referendum vote that will take place this Sunday, plus the euro rallies then sells off, and another week data print from New...
BIS: 26.28 (-0.60)
Two more triple-levered biotech ETFs launch
Seeking Alpha - at Seeking Alpha - Tue Jun 23, 8:22AM CDT
BBP: 36.06 (+0.48), PBE: 59.48 (+0.62), BBC: 36.17 (+0.44), SBIO: 37.90 (+0.49), BIS: 26.28 (-0.60), HQL: 29.86 (+0.30), FBT: 126.39 (+1.33), BIB: 96.36 (+1.83), XBI: 255.44 (+2.98), BBH: 139.92 (+1.40), IBB: 382.53 (+3.73), LABU: 48.14 (+1.67), LABD: 28.86 (-1.08)
Biotech Bio-Hazard
James Stefurak, CFA - at Seeking Alpha - Tue Jun 16, 10:58AM CDT
BIIB: 318.78 (+1.78), BIS: 26.28 (-0.60), GILD: 117.86 (-0.04), IBB: 382.53 (+3.73), AMGN: 176.59 (+4.90), AAPL: 121.30 (-1.07), CELG: 131.25 (-0.63)
Why I'm Shorting Biotech
George Budwell, The Motley Fool - Motley Fool - Sat Jun 13, 12:16PM CDT
Biotech and biopharma have had an incredible run over the past few years. And like many investors, I've been able to crush the broader markets simply by buying and holding top names in the industry like AbbVie , Gilead Sciences , and Isis...
ESRX: 90.07 (-0.18), BIS: 26.28 (-0.60), ISIS: 54.93 (+1.76), GILD: 117.86 (-0.04), MRK: 58.96 (+0.44), IBB: 382.53 (+3.73), ABBV: 70.01 (-0.15), BMY: 65.64 (+1.18), CELG: 131.25 (-0.63)
Intro Guide to Leveraged Biotech ETF Investing - ETF News And Commentary
Eric Dutram - Zacks Investment Research - Tue Jun 09, 11:08AM CDT
A quick discussion of the ways investors can play the biotechnology sector with leverage.
BIS: 26.28 (-0.60), BIB: 96.36 (+1.83), LABU: 48.14 (+1.67), LABD: 28.86 (-1.08)
When Genius Fails Again, Part I
Addison Wiggin - Daily Reckoning - Fri May 22, 3:06PM CDT
This post When Genius Fails Again, Part I appeared first on Daily Reckoning . Addison takes a look behind the curtain during a seminal moment in The Daily Reckoning’s history… The post When Genius Fails Again, Part I appeared first on Daily...
BIS: 26.28 (-0.60)
Hidden Gems In This Market Cycle's Leading Theme
Cam Hui, CFA - Seeking Alpha - Fri May 08, 5:18AM CDT
Philosophical Economics wrote a terrific post yesterday about how the "Winner take all" economy is affecting companies and the competitive environment. He observed that net margins have been elevated in the last few years. Generally, when...
BIS: 26.28 (-0.60), BIB: 96.36 (+1.83), IBB: 382.53 (+3.73)
FDA to hold public meeting on off-label drug promotion
Seeking Alpha - at Seeking Alpha - Thu May 07, 10:13AM CDT
ABT: 50.69 (-0.08), BIB: 96.36 (+1.83), PFE: 36.06 (+0.33), IBB: 382.53 (+3.73), DRGS: 60.10 (-0.69), LLY: 84.51 (-0.03), BMY: 65.64 (+1.18), GSK: 43.44 (-0.15), JNJ: 100.21 (+0.37), BIS: 26.28 (-0.60), AZN: 33.79 (+0.05), MRK: 58.96 (+0.44), ABBV: 70.01 (-0.15), SNY: 53.99 (+0.42), IRY: 54.63 (+0.19), IXJ: 112.86 (+0.60), NVS: 103.75 (+0.57)
Biotechs continue slide
Seeking Alpha - at Seeking Alpha - Wed Apr 29, 11:42AM CDT
BIS: 26.28 (-0.60), BIB: 96.36 (+1.83), IBB: 382.53 (+3.73)
Drug makers getting visability over aggressive pricing practices
Seeking Alpha - at Seeking Alpha - Mon Apr 27, 10:19AM CDT
MNK: 123.96 (+2.26), BIS: 26.28 (-0.60), VRX: 257.53 (+3.25), BIB: 96.36 (+1.83), IBB: 382.53 (+3.73), DRGS: 60.10 (-0.69)
U.S. drug spending rose 13% in 2014
Seeking Alpha - at Seeking Alpha - Tue Apr 14, 6:28AM CDT
BIS: 26.28 (-0.60), BIB: 96.36 (+1.83), IBB: 382.53 (+3.73), DRGS: 60.10 (-0.69), IXJ: 112.86 (+0.60), IRY: 54.63 (+0.19)
Infographic: Developing Economies Graying Faster
The Financialist - at Seeking Alpha - Thu Apr 09, 4:38PM CDT
(click to enlarge) Original post Read comments Read more articles from Seeking Alpha: Our Second Best Performing Stock For First Quarter 2015 - Maiden Holdings, Ltd. Rich Middle Class, Poor Middle Class Why Investors Shouldn't...
BIS: 26.28 (-0.60), BIB: 96.36 (+1.83), IBB: 382.53 (+3.73), DRGS: 60.10 (-0.69), IXJ: 112.86 (+0.60), IRY: 54.63 (+0.19)
BUYINS.NET: BIS, Has Remained On Naked Short Lists 13 Consecutive Days
M2 - Tue Mar 31, 4:21AM CDT
BUYINS.NET, www.buyins.net , announced today that these select companies have been Has Remained On the NASDAQ, AMEX, NYSE, OTCBB and Pinksheet naked short threshold lists. ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS). For a complete list of companies on the naked short lists please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to http://www.buyins.net .
BIS: 26.28 (-0.60)
BIS vs. IBB is The 'Chart of the Day'
at The Street - Thu Mar 26, 9:14AM CDT
The BIS vs. IBB is the OptionsProfits 'Chart of the Day.'
BIS: 26.28 (-0.60), IBB: 382.53 (+3.73)
Biotechs selling off on increased volume
Seeking Alpha - at Seeking Alpha - Wed Mar 25, 11:13AM CDT
BIS: 26.28 (-0.60), BIB: 96.36 (+1.83), IBB: 382.53 (+3.73)
FDA to assess homeopathy business
Seeking Alpha - at Seeking Alpha - Tue Mar 24, 3:42PM CDT
BIS: 26.28 (-0.60), BIB: 96.36 (+1.83), IBB: 382.53 (+3.73), DRGS: 60.10 (-0.69), IXJ: 112.86 (+0.60), IRY: 54.63 (+0.19)
2015-0319 - Index - CSE Composite Index Quarterly Rebalancing
Marketwire Canada - Thu Mar 19, 3:06PM CDT
The quarterly rebalancing of the CSE Composite Index will result in the following changes, effective after the close on Friday, March 20, 2015.
SEE: 53.17 (+0.19), GFI: 2.76 (+0.16), BIS: 26.28 (-0.60), ACH: 8.62 (-0.16), BOI: 15.27 (+0.05)
Pharma and Biotech M&A deals reached $212B last year
Seeking Alpha - at Seeking Alpha - Thu Mar 19, 10:45AM CDT
BIS: 26.28 (-0.60), BIB: 96.36 (+1.83), IBB: 382.53 (+3.73), DRGS: 60.10 (-0.69), IXJ: 112.86 (+0.60), IRY: 54.63 (+0.19)
BlackIce Enterprise Sponsors Vietnam Seminar on Basel II Implementation
ACCESSWIRE - Tue Jan 13, 4:02PM CST
Vancouver, BC / ACCESSWIRE / January 13, 2015 / BlackIce Enterprise Risk Management Inc. (BlackIce) (CSE: BIS), along with IBM, is a co-sponsor of the 'Leverage ICAAP for Basel II Implementation' seminar to be held in Hanoi, Vietnam on Thursday January 15, 2015.
BIS: 26.28 (-0.60), IBM: 161.99 (+1.03)
What The ECB Will Do
Chuck Butler - Daily Reckoning - Tue Jun 30, 9:35AM CDT
This post What The ECB Will Do appeared first on Daily Reckoning . Chuck Butler explains the breakdown of the Greek referendum vote that will take place this Sunday, plus the euro rallies then sells off, and another week data print from New...
BIS: 26.28 (-0.60)
Two more triple-levered biotech ETFs launch
Seeking Alpha - at Seeking Alpha - Tue Jun 23, 8:22AM CDT
BBP: 36.06 (+0.48), PBE: 59.48 (+0.62), BBC: 36.17 (+0.44), SBIO: 37.90 (+0.49), BIS: 26.28 (-0.60), HQL: 29.86 (+0.30), FBT: 126.39 (+1.33), BIB: 96.36 (+1.83), XBI: 255.44 (+2.98), BBH: 139.92 (+1.40), IBB: 382.53 (+3.73), LABU: 48.14 (+1.67), LABD: 28.86 (-1.08)
Biotech Bio-Hazard
James Stefurak, CFA - at Seeking Alpha - Tue Jun 16, 10:58AM CDT
BIIB: 318.78 (+1.78), BIS: 26.28 (-0.60), GILD: 117.86 (-0.04), IBB: 382.53 (+3.73), AMGN: 176.59 (+4.90), AAPL: 121.30 (-1.07), CELG: 131.25 (-0.63)
Why I'm Shorting Biotech
George Budwell, The Motley Fool - Motley Fool - Sat Jun 13, 12:16PM CDT
Biotech and biopharma have had an incredible run over the past few years. And like many investors, I've been able to crush the broader markets simply by buying and holding top names in the industry like AbbVie , Gilead Sciences , and Isis...
ESRX: 90.07 (-0.18), BIS: 26.28 (-0.60), ISIS: 54.93 (+1.76), GILD: 117.86 (-0.04), MRK: 58.96 (+0.44), IBB: 382.53 (+3.73), ABBV: 70.01 (-0.15), BMY: 65.64 (+1.18), CELG: 131.25 (-0.63)
Intro Guide to Leveraged Biotech ETF Investing - ETF News And Commentary
Eric Dutram - Zacks Investment Research - Tue Jun 09, 11:08AM CDT
A quick discussion of the ways investors can play the biotechnology sector with leverage.
BIS: 26.28 (-0.60), BIB: 96.36 (+1.83), LABU: 48.14 (+1.67), LABD: 28.86 (-1.08)
When Genius Fails Again, Part I
Addison Wiggin - Daily Reckoning - Fri May 22, 3:06PM CDT
This post When Genius Fails Again, Part I appeared first on Daily Reckoning . Addison takes a look behind the curtain during a seminal moment in The Daily Reckoning’s history… The post When Genius Fails Again, Part I appeared first on Daily...
BIS: 26.28 (-0.60)
Hidden Gems In This Market Cycle's Leading Theme
Cam Hui, CFA - Seeking Alpha - Fri May 08, 5:18AM CDT
Philosophical Economics wrote a terrific post yesterday about how the "Winner take all" economy is affecting companies and the competitive environment. He observed that net margins have been elevated in the last few years. Generally, when...
BIS: 26.28 (-0.60), BIB: 96.36 (+1.83), IBB: 382.53 (+3.73)
FDA to hold public meeting on off-label drug promotion
Seeking Alpha - at Seeking Alpha - Thu May 07, 10:13AM CDT
ABT: 50.69 (-0.08), BIB: 96.36 (+1.83), PFE: 36.06 (+0.33), IBB: 382.53 (+3.73), DRGS: 60.10 (-0.69), LLY: 84.51 (-0.03), BMY: 65.64 (+1.18), GSK: 43.44 (-0.15), JNJ: 100.21 (+0.37), BIS: 26.28 (-0.60), AZN: 33.79 (+0.05), MRK: 58.96 (+0.44), ABBV: 70.01 (-0.15), SNY: 53.99 (+0.42), IRY: 54.63 (+0.19), IXJ: 112.86 (+0.60), NVS: 103.75 (+0.57)
Biotechs continue slide
Seeking Alpha - at Seeking Alpha - Wed Apr 29, 11:42AM CDT
BIS: 26.28 (-0.60), BIB: 96.36 (+1.83), IBB: 382.53 (+3.73)
Drug makers getting visability over aggressive pricing practices
Seeking Alpha - at Seeking Alpha - Mon Apr 27, 10:19AM CDT
MNK: 123.96 (+2.26), BIS: 26.28 (-0.60), VRX: 257.53 (+3.25), BIB: 96.36 (+1.83), IBB: 382.53 (+3.73), DRGS: 60.10 (-0.69)
U.S. drug spending rose 13% in 2014
Seeking Alpha - at Seeking Alpha - Tue Apr 14, 6:28AM CDT
BIS: 26.28 (-0.60), BIB: 96.36 (+1.83), IBB: 382.53 (+3.73), DRGS: 60.10 (-0.69), IXJ: 112.86 (+0.60), IRY: 54.63 (+0.19)
Infographic: Developing Economies Graying Faster
The Financialist - at Seeking Alpha - Thu Apr 09, 4:38PM CDT
(click to enlarge) Original post Read comments Read more articles from Seeking Alpha: Our Second Best Performing Stock For First Quarter 2015 - Maiden Holdings, Ltd. Rich Middle Class, Poor Middle Class Why Investors Shouldn't...
BIS: 26.28 (-0.60), BIB: 96.36 (+1.83), IBB: 382.53 (+3.73), DRGS: 60.10 (-0.69), IXJ: 112.86 (+0.60), IRY: 54.63 (+0.19)
BUYINS.NET: BIS, Has Remained On Naked Short Lists 13 Consecutive Days
M2 - Tue Mar 31, 4:21AM CDT
BUYINS.NET, www.buyins.net , announced today that these select companies have been Has Remained On the NASDAQ, AMEX, NYSE, OTCBB and Pinksheet naked short threshold lists. ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS). For a complete list of companies on the naked short lists please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to http://www.buyins.net .
BIS: 26.28 (-0.60)
BIS vs. IBB is The 'Chart of the Day'
at The Street - Thu Mar 26, 9:14AM CDT
The BIS vs. IBB is the OptionsProfits 'Chart of the Day.'
BIS: 26.28 (-0.60), IBB: 382.53 (+3.73)
Biotechs selling off on increased volume
Seeking Alpha - at Seeking Alpha - Wed Mar 25, 11:13AM CDT
BIS: 26.28 (-0.60), BIB: 96.36 (+1.83), IBB: 382.53 (+3.73)
FDA to assess homeopathy business
Seeking Alpha - at Seeking Alpha - Tue Mar 24, 3:42PM CDT
BIS: 26.28 (-0.60), BIB: 96.36 (+1.83), IBB: 382.53 (+3.73), DRGS: 60.10 (-0.69), IXJ: 112.86 (+0.60), IRY: 54.63 (+0.19)
2015-0319 - Index - CSE Composite Index Quarterly Rebalancing
Marketwire Canada - Thu Mar 19, 3:06PM CDT
The quarterly rebalancing of the CSE Composite Index will result in the following changes, effective after the close on Friday, March 20, 2015.
SEE: 53.17 (+0.19), GFI: 2.76 (+0.16), BIS: 26.28 (-0.60), ACH: 8.62 (-0.16), BOI: 15.27 (+0.05)
Pharma and Biotech M&A deals reached $212B last year
Seeking Alpha - at Seeking Alpha - Thu Mar 19, 10:45AM CDT
BIS: 26.28 (-0.60), BIB: 96.36 (+1.83), IBB: 382.53 (+3.73), DRGS: 60.10 (-0.69), IXJ: 112.86 (+0.60), IRY: 54.63 (+0.19)
BlackIce Enterprise Sponsors Vietnam Seminar on Basel II Implementation
ACCESSWIRE - Tue Jan 13, 4:02PM CST
Vancouver, BC / ACCESSWIRE / January 13, 2015 / BlackIce Enterprise Risk Management Inc. (BlackIce) (CSE: BIS), along with IBM, is a co-sponsor of the 'Leverage ICAAP for Basel II Implementation' seminar to be held in Hanoi, Vietnam on Thursday January 15, 2015.
BIS: 26.28 (-0.60), IBM: 161.99 (+1.03)
(0)
(0)